Skip to content
Movie Casting Call
Author:
Hematogenix
Hematogenix’s MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb’s ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma
August 19, 2026